|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/24 | |
| A61P 37/06 | |||
| G01N 33/53 | |||
| C07K 14/54 |
| (11) | Number of the document | 2027157 |
| (13) | Kind of document | T |
| (96) | European patent application number | 07786719.0 |
| Date of filing the European patent application | 2007-05-23 | |
| (97) | Date of publication of the European application | 2009-02-25 |
| (45) | Date of publication and mention of the grant of the patent | 2014-08-06 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2007/055029 |
| Date | 2007-05-23 |
| (87) | Number | WO 2007/137984 |
| Date | 2007-12-06 |
| (30) | Number | Date | Country code |
| 0610438 | 2006-05-25 | GB | |
| 0611046 | 2006-06-05 | GB |
| (72) |
ELLIS, Jonathan Henry, GB
GERMASCHEWSKI, Volker, GB
HAMBLIN, Paul Andrew, GB
KIRBY, Ian, GB
|
| (73) |
Glaxo Group Limited,
980 Great West Road, Brentford, Middlesex TW8 9GS,
GB
|
| (54) | MODIFIED HUMANISED ANTI-INTERLEUKIN-18 ANTIBODIES |
| MODIFIED HUMANISED ANTI-INTERLEUKIN-18 ANTIBODIES |